Clinical Trial Update: CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD) [NA]

View source ↗

Summary

A clinical trial evaluating CryoSpray Ablation for malignant airway disease in lung cancer and mesothelioma was terminated, with safety and tissue effect result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Mesothelioma

Drugs mentioned

• CryoSpray Ablation

Snippet

Sponsor: CSA Medical, Inc. | Conditions: Lung Cancer, Mesothelioma | NA | Status: TERMINATED | Results posted: 2014-07-16